Latest news
INmune Bio Advances Ebstrocel Regulatory Filings and Clinical Plans - sekbernews.idsekbernews.id · Sat, 08 Aug 2026 08:00:22 GMTINmune Bio Inc. - Common stock (INMB) Stock Price, News, Quote & History - FinancialContentFinancialContent · Fri, 07 Aug 2026 09:10:00 GMTINmune Bio Q2 2026 Earnings: Tax-Credit Benefit Narrows Net Loss - TradingKeyTradingKey · Fri, 07 Aug 2026 01:47:48 GMTINmune Bio Q2 2026 earnings: Tax rebate benefit narrows net loss - TradingKeyTradingKey · Thu, 06 Aug 2026 21:49:15 GMTINMB: Ebstrocel nears global filings as financials strengthen and XPro advances in Alzheimer's - TradingViewTradingView · Thu, 06 Aug 2026 21:30:58 GMTINmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:56 GMTScientific advisory board tasked with setting path for fragile skin treatment - Epidermolysis Bullosa NewsEpidermolysis Bullosa News · Sat, 01 Aug 2026 10:53:05 GMT